Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 5/20 | 0.64 |
| ▸ | CA2 | P00918 | 5/20 | 0.64 |
| ▸ | CA12 | O43570 | 4/20 | 0.64 |
| ▸ | CA9 | Q16790 | 4/20 | 0.64 |
| ▸ | CA3 | P07451 | 3/20 | 0.64 |
| ▸ | CA6 | P23280 | 3/20 | 0.64 |
| ▸ | CA5A | P35218 | 3/20 | 0.64 |
| ▸ | CA7 | P43166 | 3/20 | 0.64 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.64 |
| ▸ | CA4 | P22748 | 2/20 | 0.64 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.64 |
| ▸ | MMP1 | P03956 | 1/20 | 0.64 |
| ▸ | MMP2 | P08253 | 1/20 | 0.64 |
| ▸ | MMP9 | P14780 | 1/20 | 0.64 |
| ▸ | MMP8 | P22894 | 1/20 | 0.64 |
| ▸ | MMP13 | P45452 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11511689 | 0.98 | GAA (0.95) | GAASMN1; SMN2CA1CA2CA12 | |
| SCHEMBL28678466 | 0.98 | GAA (0.95) | GAASMN1; SMN2CA1CA2CA12 | |
| SCHEMBL7629070 | 0.89 | SMN1; SMN2 (0.80) | GAASMN1; SMN2CA1CA2CA12 | |
| SCHEMBL8736878 | 0.88 | SMN1; SMN2 (0.85) | GAASMN1; SMN2CA1CA2CA12 | |
| SCHEMBL7627224 | 0.82 | ALDH1A1 (0.72) | GAASMN1; SMN2CA1CA2CA12 | |
| SCHEMBL8080277 | 0.82 | SMN1; SMN2 (0.70) | GAASMN1; SMN2CA1CA2CA12 | |
| SCHEMBL187561 | 0.82 | GAA (0.70) | GAASMN1; SMN2CA1CA2CA12 | |
| SCHEMBL418582 | 0.81 | GAA (0.68) | GAASMN1; SMN2CA1CA2CA12 | |
| Potassium SCHEMBL29525387 | 0.80 | GAA (0.67) | GAASMN1; SMN2CA1CA2CA12 | |
| SCHEMBL10950543 | 0.80 | GAA (0.67) | GAASMN1; SMN2CA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745119-A1 | ISOCYANATE COMPOSITION | Hanwha Solutions Corporation (KR) | 2026-05-20 | — | — | EP | claimed |
| EP-4714928-A1 | A REACTIVE RESIN COMPOSITION COMPRISING A PEROXIDE-FREE INITIATOR SYSTEM WITH A HETEROCYCLIC COMPOUND COMPRISING AT LEAST ONE N-N SINGLE BOND | Hilti Aktiengesellschaft (LI) | 2026-03-25 | — | — | EP | claimed |
| EP-4714926-A1 | A REACTIVE RESIN COMPOSITION COMPRISING A PEROXIDE-FREE INITIATOR SYSTEM WITH A TERTIARY AMINE | Hilti Aktiengesellschaft (LI) | 2026-03-25 | — | — | EP | claimed |
| EP-4714925-A1 | A REACTIVE RESIN COMPOSITION COMPRISING A PEROXIDE-FREE INITIATOR SYSTEM | Hilti Aktiengesellschaft (LI) | 2026-03-25 | — | — | EP | claimed |
| EP-4714927-A1 | A REACTIVE RESIN COMPOSITION COMPRISING A PEROXIDE-FREE INITIATOR SYSTEM WITH A SULFINATE AND A TERTIARY AMINE | Hilti Aktiengesellschaft (LI) | 2026-03-25 | — | — | EP | claimed |
| US-20260022096-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | GENECODE (EE) | 2026-01-22 | — | — | US | claimed |
| CN-120117949-A | Method for directly preparing tertiary amine compound from aromatic aldehyde, ketone and secondary amine | 湖南大学 | 2025-06-10 | — | — | CN | claimed |
| WO-2025047017-A1 | SUBSTRATE TREATMENT METHOD, SUBSTRATE TREATMENT APPARATUS, AND TREATMENT SOLUTION | 株式会社ＳＣＲＥＥＮホールディングス | 2025-03-06 | — | — | WO | claimed |
| CN-119528773-A | N-alkylation method of sulfonamide compound | 赣南医科大学 | 2025-02-28 | — | — | CN | claimed |
| WO-2025042219-A1 | ISOCYANATE COMPOSITION | 한화솔루션 주식회사 | 2025-02-27 | — | — | WO | claimed |
| EP-0830421-A1 | MODIFIED AMINO CROSSLINKING AGENTS | CYTEC TECHNOLOGY CORP. (US) | 1998-03-25 | — | — | EP | claimed |
| EP-0825025-A1 | Hot-melt ink-jet printhead | Océ-Technologies B.V. (NL) | 1998-02-25 | — | — | EP | claimed |
| EP-0825028-A1 | Hot-melt ink-jet printhead | Océ-Technologies B.V. (NL) | 1998-02-25 | — | — | EP | claimed |
| US-5612084-A | COATING, CURING, CROSSLINKING; LOW VOLATILITY; RECEPTIVITY | CYTEC TECHNOLOGY CORP. (US) | 1997-03-18 | — | — | US | claimed |
| WO-1996040825-A1 | MODIFIED AMINO CROSSLINKING AGENTS | CYTEC TECHNOLOGY CORP. (US) | 1996-12-19 | — | — | WO | claimed |
| EP-0604980-A1 | Aminoplast-anchored ultraviolet light stabilizers | CYTEC TECHNOLOGY CORP. (US) | 1994-07-06 | — | — | EP | claimed |
| EP-0104353-B1 | HEAT SENSITIVE RECORD MATERIAL | HODOGAYA CHEMICAL CO., LTD. (JP) | 1987-10-28 | — | — | EP | claimed |
| EP-0178450-A2 | Metal complexes to which an immunologically active material can be or is coupled, their preparation and use | F. HOFFMANN-LA ROCHE AG (CH) | 1986-04-23 | — | — | EP | claimed |
| US-4482905-A | FLUORAN, BENZENESULFONAMIDE, ACID, BINDER | HODOGAYA CHEMICAL CO., LTD. (JP) | 1984-11-13 | — | — | US | claimed |
| EP-0104353-A2 | Heat sensitive record material | HODOGAYA CHEMICAL CO., LTD. (JP) | 1984-04-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022096-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | CNR1, CDR2, SMN1; SMN2 | GAA 2022/4885SMN1; SMN2 3/4885CA1 93/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.